Protegemos tu salud a través de la Ciencia
Investigación
Análisis espacial e impacto ambiental en enfermedades transmisibles
Líneas de investigación
Contenidos con Investigacion .
Análisis espacial e impacto ambiental en enfermedades transmisibles
- Análisis espacio temporal de enfermedades transmisibles
- Análisis del impacto ambiental en la transmisión y difusión de enfermedades infecciosas
- Mortalidad diaria, factores meteorológicos y cambio climático
Publicaciones destacadas
Modeling the regional distribution of international travelers in Spain to estimate imported cases of dengue and malaria: statistical inference and validation study.
García-García D, Fernández-Martínez B, Bartumeus F, et al. JMIR Public Health Surveill. 2024;10:e51191.
PUBMEDThe impact of meteorological factors on tuberculosis incidence in Spain: a spatiotemporal analysis.
Díez Galán MDM, Redondo-Bravo L, Gómez-Barroso D, et al. Epidemiol Infect. 2024 Mar 20;152:e58.
PUBMEDDetection of dengue in German tourists returning from Ibiza, Spain, related to an autochthonous outbreak, August to October 2022.
García-San-Miguel L, Giménez-Durán J, Saravia-Campelli G, et al. Euro Surveill. 2024;29(14):pii=2300296.
PUBMEDSpatial analysis for risk assessment of dengue in Spain.
Fernández-Martínez B, Pampaka D, Suárez-Sánchez P, et al. Enferm Infecc Microbiol Clin (Engl Ed) . 2023 Nov 7:S2529-993X(23)00257-5.
PUBMEDA systematic review of environmental factors related to WNV circulation in European and Mediterranean countries.
Giesen C, Herrador Z, Fernandez-Martinez B, et al. One Health . 2023 Jan 6:16:100478.
PUBMEDToxoplasma gondii exposure in wildlife in Spain: Is there any predictable threat for humans and domestic animals?
González-Barrio D, Carpio AJ, Preite L, Miguel-Vicedo M, Estévez-Reboredo RM, González-Viadero M, Barba-Sánchez R, Calero-Bernal R, Carmena D, Fuentes I. Sci Total Environ. 2024 Jul 20;935:173290. doi: 10.1016/j.scitotenv.2024.173290. Epub 2024 May 21. PMID: 38782291.
PUBMEDScabies in Spain? A comprehensive epidemiological picture
Redondo-Bravo L, Fernandez-Martinez B, Gómez-Barroso D, Gherasim A, García-Gómez M, Benito A, Herrador Z. PLoS One. 2021 Nov 1;16(11):e0258780. doi: 10.1371/journal.pone.0258780. eCollection 2021. PMID: 34723979 Free PMC article.
PUBMEDUnprecedented increase of West Nile virus neuroinvasive disease, Spain, summer 2020.
García San Miguel L, Fernández-Martínez B, Sierra Moros MJ, Vázquez A, Julián Pachés P, García Villacieros E, Gómez Martín MB, Figuerola Borras J, Lorusso N, Ramos Aceitero JM, Moro E, de Celis A, Oyonarte S, Mahillo B, Romero González LJ, Sánchez-Seco MP, Suárez Rodríguez B, Ameyugo Catalán U, Ruiz Contreras S, Pérez-Olmeda M, Simón Soria F. Euro Surveill. 2021;26(19):pii=2002010. doi.org/10.2807/1560-7917.
PUBMEDEpidemiology and control of human immunodeficiency and hepatitis C virus in Spanish prisons over the last 30 years: towards the achievement of sustainable development goals.
Hernando V, Filipe Santos C, Cuenca N, del Amo J, Diaz A, Acín E, Martinez-Aznar C. Public Health. 2025; 251:106097.
PUBMED DOIProjecting changes in demographics and causes of death in people with HIV in western Europe from 2025 to 2050: a mathematical modelling study.
Ambia J, van Sighem A, Pantazis N, Gill MJ, Grabar S, Monforte AD, Zangerle R, Bruguera A, Teira R, Jarrin I, Vehreschild J, Cavassini M, van der Valk M, Bonnet F, Sterne JAC, Ingle SM, Trickey A. Lancet HIV. 2025 Nov 7:S2352-3018(25)00197-3.
PUBMED DOIScoping review of infectious disease prevention, mitigation and management in passenger ships and at ports: mapping the literature to develop comprehensive and effective public health measures
Angelos Amditis, Spyridon Athanasiadis, Szava J. Bansaghi, Despoina A. Bygvraa, Stefanos Chatzimichelakis, Reuben D’Souza, Dimitra Dionysiou, Maria Guerrero-Vadillo, Giorgio Guzzetta, Volker Harth, Jan Heidrich, Jörn Klein, Jürgen F. Kolb, Prashant Kumar, Pierfrancesco Lepore, Sergiu Lupu, Valentina Marziano, Johannes Neumann, Symeon Nikolaou, Filip Nistor, Eleftherios Ouzounoglou, Vassilis Papataxiarhis, Marina Peñuelas, Patrizio Pezzotti, Catalin Popa, Raphael Rataj, Smaragda Reppa, Flavia Riccardo, Hannu Salmela, Niko Siilin, Konstantinos Theofilis, Constantinos Tsibanis, Carmen Varela, Nikolaos P. Ventikos, Georgios Vosinakis, Goran Vukelić, Christine Zädow & Vassilios Zagkas.
PUBMED DOIEstimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain.
Mazagatos C, Mendioroz J, Rumayor MB, Gallardo García V, Álvarez Río V, Cebollada Gracia AD, et al. Influenza Other Respir Viruses. 2024 May;18(5):e13294.
PUBMED DOIAssociation between type of alcoholic beverage and all-cause mortality. A population-based prospective study.
Fontán-Vela J, Ortiz C, López-Cuadrado T, Téllez-Plaza M, García-Esquinas E, Ortolá R, Rodríguez-Artalejo F, Galán I. Association between type of alcoholic beverage and all-cause mortality. A population-based prospective study. Public Health. 2025 Jun;243:105728.
PUBMED DOIImpact of a community-based multisectoral intervention on the health of individuals with parkinson's disease and their family caregivers.
Calzada García M, Ayala A, Navarta Sánchez MV, Palmar Santos AM, Portillo MC, González García B, Carabajal Pendón E, López Manzanares L, Pedraz Marcos A. Impacto de una intervención multisectorial comunitaria en la salud de las personas con enfermedad de Parkinson y sus familiares cuidadores [Impact of a community-based multisectoral intervention on the health of individuals with parkinson's disease and their family caregivers]. Semergen. 2026 Mar;52(2):102694. Spanish.
PUBMED DOIEnfermedad meningocócica invasiva en España en 2024.
Martín-Sánchez A, del Águila Mejía J, Acosta-Gutiérrez M, Soler-Soneira M, Cano-Portero R, Masa-Calles J. Boletín Epidemiológico Semanal. 2025;33(3):135-152.
DOITwo-season effectiveness of a single nirsevimab dose against RSV hospitalisation in healthy term-born infants: a population-based case–control study, Spain, October 2023 to March 2025.
Núñez O, Juaneda J, (...), Monge S, Pastor-Barriuso R., the Nirsevimab Effectiveness Study Collaborators. Two-season effectiveness of a single nirsevimab dose against RSV hospitalisation in healthy term-born infants: a population-based case–control study, Spain, October 2023 to March 2025. Euro Surveill. 2026;31(9):pii=2500593.
DOIBreastfeeding knowledge, attitudes and practices of HIV-positive women in Africa: a systematic review
Cuenca-Viñas N, Sánchez-Marqués R, Benito A, Romay-Barja M. Breastfeeding knowledge, attitudes and practices of HIV-positive women in Africa: a systematic review. Int Breastfeed J. 2025 Sep 29;20(1):74.
PUBMED DOIAssociation of depressive symptoms with all-cause, cardiovascular, and cancer mortality: A population-based study in Spain.
López-Cuadrado T, Ortiz C, Pastor-Barriuso R, Galán I. Association of depressive symptoms with all-cause, cardiovascular, and cancer mortality: A population-based study in Spain. Span J Psychiatry Ment Health. 2026 Mar 3:S2950-2853(26)00015-3.
PUBMED DOISocio-economic inequalities in lung cancer mortality in Spain: a nation-wide study using area-based deprivation
Redondo-Sánchez D, Fernández-Navarro P, Rodríguez-Barranco M, Nuñez O, Petrova D, García-Torrecillas JM, Jiménez-Moleón JJ, Sánchez MJ. Socio-economic inequalities in lung cancer mortality in Spain: a nation-wide study using area-based deprivation. Int J Equity Health. 2023 Aug 2;22(1):145.
PUBMED DOIBiological Signatures of Inflammation Biomarkers Identified Using Data Reduction Methods in Adult Population: A Scoping Review Protocol
G.Sánchez-Gordón, E.Plans-Beriso, C.Barahona-López, et al., “Biological Signatures of Inflammation Biomarkers Identified Using Data Reduction Methods in Adult Population: A Scoping Review Protocol,” Health Science Reports9 (2026): e71903
DOIInformación adicional
Los miembros del equipo pertenecen al Ciber de Epidemiología y Salud Pública. Grupo 32:
https://www.ciberesp.es/grupos/grupo-de-investigacion?id=12557